New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
February 24, 2015
10:14 EDTAAPLSamsung reportedly reaches deal with LG, Apple to supply DRAM, Korea Times says
Subscribe for More Information
09:35 EDTVIAB, AAPLActive equity options trading on open
Subscribe for More Information
09:25 EDTJPMJPMorgan sees pro forma net income growing to about $30B over 3 year horizon
Subscribe for More Information
09:11 EDTJPMJPMorgan CFO says will 'aggressively' manage G-SIB exposures
CFO Lake says may take at actions to reduce G-SIB buffer to 4% if required actions are accretive.
09:06 EDTJPMJPMorgan CFO says company seeks to raise dividends if approved
Subscribe for More Information
09:01 EDTJPMJPMorgan expects legal costs to ease, but remain above pre-crisis levels
08:55 EDTJPMJPMorgan expect net charge offs to remain low at $4B+ in 2015
Subscribe for More Information
08:39 EDTAAPLApple near-term capital return could be less than expected, says UBS
UBS said they believe Apple could take a near-term breather on capital returns due to potential U.S. tax reform, increased dependence on debt issuance for stock buyback funding, and the potential for its board to wait for more clarity on repatriation. UBS reiterated its Buy rating and $150 price target on Apple shares.
07:21 EDTVIA Viacom reportedly planning job cuts, Bloomberg says
Subscribe for More Information
07:21 EDTJPMSecurities Industry & Financial Markets Association to hold a conference
Subscribe for More Information
06:39 EDTAAPLVisa Europe announces 'tokenisation service'
Subscribe for More Information
06:29 EDTAAPLApple hiring chip, battery experts from Samsung, Korea Times reports
Subscribe for More Information
06:27 EDTAAPLApple said to buy music plug-in and effect makker Camel Audio, MacRumors says
Subscribe for More Information
06:15 EDTJPMBanks probed for possible rigging of precious metals markets, WSJ reports
Officials in the U.S. are investigating at least 10 major banks for potential rigging of precious-metals markets, sources tell The Wall Street Journal. The DOJ's antitrust unit are investigating the price-setting process for gold, silver, palladium and platinum in London, while the CFTC has begun a civil investigation, with both agencies making requests for information, including a subpoena to HSBC (HSBC) from the CFTC. According to a source, Credit Suisse (CS), JP Morgan (JPM), UBS (UBS), Societe Generale (SCGLY), Bank of Nova Scotia (BNS), Barclays (BCS), Goldman Sachs (GS) and Deutsche Bank (DB) are also under investigation. Reference Link
06:12 EDTJPMJPMorgan plans to charge fees for deposits from large clients, WSJ says
JPMorgan is planning to charge corporate clients, hedge funds, private-equity firms, and foreign banks for deposits due to regulatory rules that impose costs on holding money viewed as "prone to fleeing" during financial stress, reports the Wall Street Journal, citing an internal memo and people familiar with the plan. Clients will be asked to pay a fee or move funds to other products such as money-fund sweep accounts. Retail customers are unaffected. Reference Link
06:06 EDTAAPLApple's market cap hits nearly $775B, CNBC reports
Apple's (AAPL) market cap has reached nearly $775B after the stock closed at a record on Monday, up over 2.7% to $133, CNBC reports. Exxon Mobil (XOM) has a market cap of about $377B. Reference Link
05:59 EDTAAPLStocks with implied volatility movement; BBRY AAPL
Subscribe for More Information
February 23, 2015
16:00 EDTAAPLOptions Update; February 23, 2015
Subscribe for More Information
15:17 EDTAAPLAOL iTunes login pact with Apple ending soon, AppleInsider says
Subscribe for More Information
15:00 EDTNVSFDA approves Farydak for treatment of multiple myeloma
The FDA approved Farydak for the treatment of patients with multiple myeloma, a form of blood cancer that arises from plasma cells, a type of white blood cell, found in bone marrow. Farydak is the first HDAC inhibitor approved to treat multiple myeloma. It is intended for patients who have received at least two prior standard therapies, including bortezomib and an immunomodulatory agent. Farydak is to be used in combination with bortezomib, a type of chemotherapy, and dexamethasone, an anti-inflammatory medication. Farydak is marketed by Novartis.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use